- Report
- October 2024
- 181 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 195 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 200 Pages
Global
From €2364EUR$2,490USD£1,994GBP
- Report
- August 2024
- 200 Pages
Global
From €2174EUR$2,290USD£1,834GBP
- Report
- September 2024
- 110 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- July 2024
- 159 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- June 2024
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- October 2024
- 195 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 194 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 191 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 191 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- November 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- September 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more